BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 28137555)

  • 21. Macrovascular venous invasion of pancreatic neuroendocrine tumours: impact on surgical outcomes and survival.
    Addeo P; d'Alessandro A; Averous G; Imperiale A; Faitot F; Goichot B; Bachellier P
    HPB (Oxford); 2019 Jun; 21(6):653-661. PubMed ID: 30522946
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Short- and long-term outcomes of laparoscopic organ-sparing resection in pancreatic neuroendocrine tumors: a single-center experience.
    Cienfuegos JA; Salguero J; Núñez-Córdoba JM; Ruiz-Canela M; Benito A; Ocaña S; Zozaya G; Martí-Cruchaga P; Pardo F; Hernández-Lizoáin JL; Rotellar F
    Surg Endosc; 2017 Oct; 31(10):3847-3857. PubMed ID: 28127714
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regional lymphadenectomy is indicated in the surgical treatment of pancreatic neuroendocrine tumors (PNETs).
    Hashim YM; Trinkaus KM; Linehan DC; Strasberg SS; Fields RC; Cao D; Hawkins WG
    Ann Surg; 2014 Feb; 259(2):197-203. PubMed ID: 24253141
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Observational study of natural history of small sporadic nonfunctioning pancreatic neuroendocrine tumors.
    Gaujoux S; Partelli S; Maire F; D'Onofrio M; Larroque B; Tamburrino D; Sauvanet A; Falconi M; Ruszniewski P
    J Clin Endocrinol Metab; 2013 Dec; 98(12):4784-9. PubMed ID: 24057286
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cystic pancreatic neuroendocrine tumors: A more favorable lesion?
    Carr RA; Bletsis P; Roch AM; House MG; Zyromski NJ; Nakeeb A; Schmidt CM; Ceppa EP
    Pancreatology; 2019 Mar; 19(2):372-376. PubMed ID: 30704851
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of extent of surgery on survival in patients with small nonfunctional pancreatic neuroendocrine tumors in the United States.
    Gratian L; Pura J; Dinan M; Roman S; Reed S; Sosa JA
    Ann Surg Oncol; 2014 Oct; 21(11):3515-21. PubMed ID: 24841347
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact and Clinical Predictors of Lymph Node Metastases in Nonfunctional Pancreatic Neuroendocrine Tumors.
    Jiang Y; Jin JB; Zhan Q; Deng XX; Shen BY
    Chin Med J (Engl); 2015 Dec; 128(24):3335-44. PubMed ID: 26668149
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A comprehensive comparison of clinicopathologic and imaging features of incidental/symptomatic non-functioning pancreatic neuroendocrine tumors: A retrospective study of a single center.
    Luo G; Liu Z; Guo M; Jin K; Xiao Z; Liu L; Liu C; Xu J; Ni Q; Long J; Yu X
    Pancreatology; 2015; 15(5):519-524. PubMed ID: 26365059
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Determinants of surgical resection for pancreatic neuroendocrine tumors.
    Doi R
    J Hepatobiliary Pancreat Sci; 2015 Aug; 22(8):610-7. PubMed ID: 25773163
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Resection Versus Observation of Small Asymptomatic Nonfunctioning Pancreatic Neuroendocrine Tumors.
    Barenboim A; Lahat G; Nachmany I; Nakache R; Goykhman Y; Geva R; Osher E; Scapa E; Wolf I; Orbach L; Brazowski E; Isakov O; Klausner JM; Lubezky N
    J Gastrointest Surg; 2020 Jun; 24(6):1366-1374. PubMed ID: 31197692
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic factors for pancreatic neuroendocrine neoplasms (pNET) and the risk of small non-functioning pNET.
    Lombardi M; De Lio N; Funel N; Sardella C; Russo D; Urbani C; Rossi G; Campani D; Martino E; Marcocci C; Boggi U; Bogazzi F
    J Endocrinol Invest; 2015 Jun; 38(6):605-13. PubMed ID: 25501604
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical significance of the preoperative main pancreatic duct dilation and neutrophil-to-lymphocyte ratio in pancreatic neuroendocrine tumors (PNETs) of the head after curative resection.
    Zhou B; Zhan C; Xiang J; Ding Y; Yan S
    BMC Endocr Disord; 2019 Nov; 19(1):123. PubMed ID: 31718651
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pancreatic Duct Involvement in Well-Differentiated Neuroendocrine Tumors is an Independent Poor Prognostic Factor.
    Nanno Y; Matsumoto I; Zen Y; Otani K; Uemura J; Toyama H; Asari S; Goto T; Ajiki T; Okano K; Suzuki Y; Takeyama Y; Fukumoto T; Ku Y
    Ann Surg Oncol; 2017 Apr; 24(4):1127-1133. PubMed ID: 27822631
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Is the 2-cm size cutoff relevant for small nonfunctioning pancreatic neuroendocrine tumors: A French multicenter study.
    Regenet N; Carrere N; Boulanger G; de Calan L; Humeau M; Arnault V; Kraimps JL; Mathonnet M; Pessaux P; Donatini G; Venara A; Christou N; Bachelier P; Hamy A; Mirallié E
    Surgery; 2016 Mar; 159(3):901-7. PubMed ID: 26590096
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Role of Surgery for Pancreatic Neuroendocrine Tumors.
    Ziogas IA; Schmitz R; Moris D; Vatsaas CJ
    Anticancer Res; 2022 Feb; 42(2):629-639. PubMed ID: 35093860
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of Outcomes Following Surgery for Locally Advanced Pancreatic Neuroendocrine Tumors.
    Titan AL; Norton JA; Fisher AT; Foster DS; Harris EJ; Worhunsky DJ; Worth PJ; Dua MM; Visser BC; Poultsides GA; Longaker MT; Jensen RT
    JAMA Netw Open; 2020 Nov; 3(11):e2024318. PubMed ID: 33146734
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognosis of sporadic resected small (≤2 cm) nonfunctional pancreatic neuroendocrine tumors - a multi-institutional study.
    Sallinen VJ; Le Large TYS; Tieftrunk E; Galeev S; Kovalenko Z; Haugvik SP; Antila A; Franklin O; Martinez-Moneo E; Robinson SM; Panzuto F; Regenet N; Muffatti F; Partelli S; Wiese D; Ruszniewski P; Dousset B; Edwin B; Bartsch DK; Sauvanet A; Falconi M; Ceyhan GO; Gaujoux S;
    HPB (Oxford); 2018 Mar; 20(3):251-259. PubMed ID: 28988702
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A rational approach to postoperative surveillance for resected non-functional pancreatic neuro-endocrine tumours.
    Feretis M; Wang T; Ghorani E; Balakrishnan A; Harper SJ; Jah A; Huguet EL; Praseedom RK; Liau SS
    Pancreatology; 2019 Oct; 19(7):1000-1007. PubMed ID: 31445889
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Robotic Central Pancreatectomy for Well-Differentiated Neuroendocrine Tumor: Parenchymal-Sparing Procedure.
    Wakabayashi T; Felli E; Cherkaoui Z; Mutter D; Marescaux J; Pessaux P
    Ann Surg Oncol; 2019 Jul; 26(7):2121. PubMed ID: 31020502
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Resection versus expectant management of small incidentally discovered nonfunctional pancreatic neuroendocrine tumors.
    Rosenberg AM; Friedmann P; Del Rivero J; Libutti SK; Laird AM
    Surgery; 2016 Jan; 159(1):302-9. PubMed ID: 26547726
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.